Cytochrome c (CC)-initiated Apaf-1 apoptosome formation represents a key initiating event in apoptosis. This process can be reconstituted in vitro with the addition of CC and ATP or dATP to cell lysates. How physiological levels of nucleotides, normally at high mM concentrations, affect apoptosome activation remains unclear. Here we show that physiological levels of nucleotides inhibit the CC-initiated apoptosome formation and caspase-9 activation by directly binding to CC on several key lysine residues and thus preventing CC interaction with Apaf-1. We show that in various apoptotic systems caspase activation is preceded or accompanied by decreases in overall intracellular NTP pools. Microinjection of nucleotides inhibits whereas experimentally reducing NTP pools enhances both CC and apoptotic stimuli-induced cell death. Our results thus suggest that the intracellular nucleotides represent critical prosurvival factors by functioning as natural inhibitors of apoptosome formation and a barrier that cells must overcome the nucleotide barrier to undergo apoptosis cell death.
INTRODUCTION
Activation of the initiator caspases represents the key event in the apoptotic process. Different from the effector caspase activation, the intrachain cleavage only modestly enhances the catalytic activities of the initiator caspases.
Rather, initiator caspase activation involves adaptor protein-mediated oligomerization. For example, caspase-8 activation involves FADD-mediated recruitment of procaspase-8 to plasma membrane death receptors resulting in proximity-induced dimerization and autocatalytic activation (Boatright et al., 2003) . Likewise, caspase-9 activation requires the adaptor protein Apaf-1 (Jiang and Wang, 2004) . Various intrinsic death stimuli compromise the integrity of the mitochondria and cause the release of cytochrome c (CC) into the cytoplasm. CC then binds to and induces oligomerization of Apaf-1 to form the ''apoptosome,'' a heptameric complex with molecular masses of $700-1400 kDa (Cain et al., 2000; Li et al., 1997; Zou et al., 1999) , leading to activation of procaspase-9.
Elegant studies by Wang and colleagues, using cell-free or recombinant protein reconstitution experiments, were the first to reveal a critical requirement for ATP or dATP [(d)ATP] in the CC-initiated apoptosome activation in vitro (Jiang and Wang, 2000; Li et al., 1997; Liu et al., 1996) . Recent work demonstrates that Apaf-591, which lacks the WD-40 repeats but retains the nucleotide and oligomerization domain (NOD), contains a tightly bound ADP molecule . Structural studies suggest that this prebound ADP molecule may play an essential function in coordinating different Apaf-1 domains and keeping Apaf-1 conformationally inactive . More recent work reveals that the full-length Apaf-1 has one molecule of dATP bound, and CC binding to Apaf-1 appears to induce hydrolysis of dATP to dADP, which subsequently exchanges for exogenous dATP to initiate apoptosome assembly (Kim et al., 2005; Yu et al., 2005) . Thus, CC binding to Apaf-1 represents the most apical and critical event in apoptosome formation and caspase activation.
In cell-free reconstitution experiments, mM to low-mM concentrations of (d)ATP are added to cell lysates, together with CC, to initiate caspase-9 activation (Cain et al., 2000; Liu et al., 1996; Zou et al., 1999) . Most mammalian cells, however, have an intracellular ATP and nucleotide pool at high-mM concentrations (e.g., Craig and Wallace, 1991; Miller and Horowitz, 1986; Mesner et al., 1999) . Therefore, it is unclear how physiological levels of nucleotides affect CC-initiated caspase activation in vivo (i.e., in the cells). Here we show that intracellular nucleotides as well as many nucleotide derivatives exert a strong inhibitory effect on the CC-initiated apoptosome formation by directly binding to CC and inhibiting the interaction of CC with Apaf-1. As microinjection of nucleotides inhibits whereas experimentally reducing NTP pools enhances both CC and apoptotic stimuli-induced cell death, our results suggest that nucleotides and nucleotide derivatives, in addition to their well-established roles in nucleic acid synthesis, energy metabolism, biosynthesis regulation, and signal transduction, also function as physiological prosurvival factors.
RESULTS

CC Initiates Caspase Activation in Fresh Cytosol without a Requirement for Exogenous Nucleotides
To determine the effects of intracellular nucleotides on caspase activation, we isolated fresh cytosol (S100) from GM701 human fibroblasts. Addition of CC, without exogenous (d)ATP, to the fresh cytosol initiated a timedependent processing of procaspase-9 to p35/37 and procaspase-3 to p24/20/17, along with the expected increases in enzymatic activity (Figures 1A and 1B) . Similar results were obtained from various cancer and primary cells ( Figure S1 ). Since (d)ATP is essential for the CC-initiated apoptosome formation and caspase activation in cell-free reconstitution experiments (Jiang and Wang, 2000; Li et al., 1997) , the above results suggest that freshly purified cytosols may contain sufficient amounts of nucleotides to assist in the CC-initiated caspase activation. Indeed, direct measurements of (d)NTP levels in six tumor cell lines and three primary cell strains revealed that these cells had ATP levels of 1.5-5 mM, and they possessed an NTP pool of $3-7 mM and a dNTP pool of $10-80 mM (Table S1 ).
Exogenous Nucleotides and Nucleotide
Intermediates Inhibit CC-Dependent Caspase Activation Most surprisingly, when we added different amounts of dATP, together with CC, to the fresh cytosol, we observed a dose-dependent inhibitory effect of dATP on the CC-initiated caspase activation. Western blot ( Figure 1C ) and caspase activity ( Figure 1D ) revealed that the inhibition occurred at 1 mM, became obvious at 2 mM, and was complete at 5 mM. Similar inhibitory effects of dATP were observed using cytosols freshly prepared from various cancer or primary cells ( Figure S1 ).
Other nucleotides such as ATP also inhibited CCinitiated caspase activation ( Figures 1E and 1F ). Like Figure S2 for general structures] also demonstrated inhibitory effects on the CC-initiated caspase activation ( Figures 1G and S3A) . The inhibitory effects of (d)ATP were unlikely due to Na + salts (Cain et al., 2001) contained in the nucleotide preparations, as their Tris forms demonstrated equipotent effects ( Figure S3B ). Moreover, pure NaCl did not exert an inhibitory effect until 75-150 mM ( Figure S3B , lane 13; data not shown). Pooled nucleotides comprising equimolar concentrations of individual nucleotides similarly showed a dose-dependent inhibition on the CC-initiated caspase activation (Figure S3C ). The inhibitory effects of (d)NTPs were independent of hydrolysis of phosphodiester bonds as three nonhydrolyzable analogs (ATPgS, AMP-PCP, and AMP-PNP) inhibited caspase-9 and -3 processing as efficiently as (d)ATP ( Figure 1H , lanes 4-6 versus lane 3 Figure 1H ). Apart from (d)NTPs or (d)NDPs, the major coenzymes, NAD, NADP, FAD, Co-A, nucleotide analogs, and phosphoribosyl pyrophosphate (PRPP; the most important precursor to nucleotide synthesis), all showed inhibitory effects ( Figures S2, S3D , and S3F). By contrast, several abundant nucleotide intermediates such as UDP-glucose (precursor of glycogen), CDP-diacylglycerol (CDP-DG; precursor of phosphoglycerides), S-adenosylmethionine (SAM; activated methyl-group donor), nucleoside analogs, D-or L-ribose, and ribose-phosphate did not show any inhibitory effect ( Figures S2, S3D , S3E, and S3F).
Nucleotides Inhibit CC-Apaf-1 Interaction, Apaf-1 Oligomerization, and Apoptosome Formation Caspase-9 activation involves Apaf-1 oligomerization/ apoptosome formation followed by sequential recruitment and activation of caspase-9 and -3 (Bratton et al., 2001) . To determine at which step nucleotides exert the inhibitory effect, we preincubated fresh cytosol with CC for different periods of time and then added dATP. The inhibitory effects of dATP on caspase-9 and -3 processing were progressively lost when dATP was added later in time ( Figure 2A ). By contrast, coaddition of CC and dATP (5 mM), or preaddition of dATP followed by CC addition to the cytosol, completely inhibited the CC-initiated caspase processing (not shown).
Since IAPs, and in particular, XIAP, bind to and inhibit caspase activity, we immunodepleted the fresh GM701 cytosol of XIAP ( Figure 2B ) and then used it in reconstitution experiments. We observed that ATP similarly inhibited the CC-induced caspase processing ( Figure 2C ). Since IAPs other than XIAP also bind to active caspases and inhibit their activity, we included in the reaction mixture the recombinant, functionally active Smac protein, which values (mean ± SD from two to three independent experiments) relative to the control. *, a nonspecific band (C, E, G, and H), is shown.
relieves the caspase inhibitory effects of all IAPs. As shown in Figure 2D , Smac did not affect the inhibitory effect of ATP on the CC-initiated caspase-9 and -3 processing. These results (Figures 2A-2D ) suggest that the inhibitory effect of nucleotides is not mediated through IAPs but rather through direct interference of apoptosome formation/function. To test this possibility, we carried out coimmunoprecipitation (co-IP) experiments in the presence or absence of dATP. The anti-CC antibody pulled down nearly all Apaf-1 in the absence of dATP ( Figure 2E ). By contrast, in the presence of inhibitory concentrations of dATP, much less Apaf-1 was coprecipitated by anti-CC antibody ( Figure 2E , lanes 4 and 5). The anti-CC antibody did not pull down caspase-9 or caspase-3 ( Figure 2E ). (E-I) Fresh GM701 cytosol was incubated with CC alone or CC plus dATP (5 mM) for 10 min at 37ºC and then used in IP with antibody to CC (E), caspase-9 (casp-9; F), Apaf-1 (G), or Rb IgG (H). In (I), the cytosol was coincubated for 1 hr at 37ºC and then used in IP with anti-Apaf-1 antibody. Western blotting was performed for the molecules indicated at the end.
Co-IP using anti-caspase-9 antibody precipitated Apaf-1 from the CC-activated cytosol but little Apaf-1 was precipitated down in the presence of dATP ( Figure 2F ). The anti-caspase-9 antibody did not pull down caspase-3 ( Figure 2F ), as previously shown (Bratton et al., 2001) . Reciprocal co-IP with anti-Apaf-1 antibody pulled down caspase-9 in the absence of dATP but not in its presence ( Figure 2G ). As expected, the Apaf-1 antibody did not bring down caspase-3 ( Figure 2G ) and the control antibody, Rb IgG, did not precipitate any molecule ( Figure 2H ). Finally, Apaf-1 IP, using cytosol that had been subjected to 1 hr preincubation with CC, coprecipitated processed caspase-9 (p37/35) as well as processed caspase-3 (p20) in the absence but not in the presence of dATP ( Figure 2I ).
If 5 mM dATP inhibits the CC interaction with Apaf-1, it should also inhibit Apaf-1 oligomerization, which was revealed by Superose 6 gel filtration chromatography experiments ( Figure 3A) . In control cytosol, Apaf-1 eluted as monomeric protein with a relative molecular mass of $158 kDa and procaspase-9 and -3 eluted as unprocessed zymogens ( Figure 3A ). In the CC-activated cytosol, most of the Apaf-1 eluted as an $700 kDa complex and procaspase-9 was completely processed to p37/35, which were associated with the complex or as the free processed form ( Figure 3A ). Caspase-processing activity (CPA) of the $700 kDa apoptosome complex ( Figure 3B , fractions 10-15) also demonstrated its functional activity. The processed caspase-3 (p20/17) eluted mostly as free form ( Figure 3A ), which coeluted with all the DEVDase activity ( Figure 3B ). Presence of dATP (5 mM) in the CCactivated cytosol completely prevented formation of the $700 kDa oligomeric active Apaf-1 complex and caspase processing and activation (Figures 3A and 3B) .
To provide the most direct evidence that high concentrations of nucleotides inhibit the CC-Apaf-1 interaction and subsequent Apaf-1 oligomerization, we used the baculovirus expression system to generate recombinant Apaf-1 XL (Apaf-1 for short), which has additional WD-40 repeats and is highly active in initiating apoptosome formation (Benedict et al., 2000) . Far Western analysis showed that 5 mM ATP directly inhibited CC binding to Control GM701 cytosol (upper), cytosol coincubated with CC alone (middle), or cytosol coincubated with CC plus dATP (5 mM), all 750 mg, were fractionated on a Superose 6 HR 10/30 column. An aliquot of each fraction was analyzed by Western blotting for Apaf-1, caspase-9, and caspase-3 (A) or used to determine the DEVDase activity (B). For caspase processing activity (CPA), 50 ml of fractions 7-17 was incubated with recombinant procaspase-3 (300 nM) for 1 hr followed by DEVDase activity measurement. DEVDase and CPA activities are presented as arbitrary unit.
recombinant Apaf-1 immobilized on the PVDF membrane ( Figure 4A ).
Subsequently, we carried out reconstitution experiments using recombinant Apaf-1 and in vitro-translated (IVT), 35 S-labeled procaspase-9. Coincubation of Apaf-1, procaspase-9, and CC in the absence of nucleotides did not result in caspase-9 processing ( Figure Interestingly, cyclic ADP-ribose ( Figure S2P ) did not inhibit caspase-9 processing ( Figure 4B , lanes 7-10). To determine whether the inhibition of apoptosome-mediated caspase-9 processing, in this pure recombinant system, was associated with hindrance in Apaf-1 oligomerization or inhibition of caspase-9 autoprocessing, we evaluated the CC-induced Apaf-1 oligomerization in the presence of a low versus high concentration of ATP. As shown in Figure 4D , although 0.5 mM ATP induced robust Apaf-1 oligomerization leading to the formation of $700 kDa active apoptosome complex, 5 mM ATP abrogated the CC-initiated Apaf-1 oligomerization.
Nucleotides Directly Bind to CC: Critical Roles of Lysine Residues
It is well known that CC interaction with its natural redox partners in the respiratory chain (i.e., CC reductase and CC oxidase) involves electrostatic interactions. Therefore, it was possible that physiological levels of nucleotides might directly bind CC via electrostatic interactions and consequently prevent CC from binding to Apaf-1. If this were the case, nucleotides should not demonstrate significant inhibitory effects on caspase activation initiated by an Apaf-1 mutant that does not bind CC but still retains the ability to activate caspase-9. We tested this postulate by using Apaf-543 (i.e., the aa 1-543 fragment; courtesy of S. Kornbluth), an Apaf-1 mutant that lacks the WD-40 domain. As shown in Figure S4A , the Apaf-543 (but not Apaf-1 CARD domain) initiated caspase-9 activation without requiring CC, consistent with earlier observations (Srinivasula et al., 1998) . Remarkably, ATP at up to 10 mM only slightly inhibited the caspase-9 activation initiated by Apaf-543 ( Figure S4A ). To prospectively identify the potential amino acid residues on the CC that mediate nucleotide binding, we employed the sensitive matrix-assisted laser desorption/ ionization mass spectrometry (MALDI-MS) approach.
The results revealed a concentration-dependent increase in ATP (mass = 506 ± 4 Da) binding to CC (12,231 Da), with 1-3 ATP molecules (CC + 1 ATP ligand = 12,737 ± 5 Da) binding at 10-100 mM ( Figures 5B and 5C ), up to 5 ATP molecules binding at 0.5-1 mM ( Figures 5D and  S4C) , and 5-7 ATP molecules binding at 2-5 mM ( Figure 5E ; data not shown). The complex formed between CC and ATP was due to noncovalent interactions as no ligand binding was observed following desalting of the sample on a protein trap and column followed by ESI-MS analysis (not shown). Peptide mapping and LC-MS/MS using photoaffinity probe 8-azido-ATP revealed 11 sites with a +28 Da modification at presumed ATP binding sites (Table  S2) . These were K7, K8, K13, K25, K27, K39, K72, K73, K86, K87, and K88 (Table S2 and Figure 5F ), which represent 11 of the 18 lysine (K) residues in CC.
Similar to ATP, 2 mM of CTP (not shown), dATP (Figure S4D ), NTP pool ( Figure S4E ), dNTP pool ( Figure S4F ), and NADP (not shown) also demonstrated binding to CC. In contrast to ATP and other nucleotides, 2 mM of ADP and AMP demonstrated much reduced or no binding to CC (Figures 5G and 5H) . To directly test the relationship between ATP binding to CC and CC-mediated caspase activation, we preincubated CC with 2 or 5 mM ATP and then removed the unbound ATP through dialysis. As shown in Figure 5I , CC prebound with ATP failed to activate Apaf-1-mediated caspase-9 cleavage (lanes 6-8).
Four of the eleven K residues identified (i.e., K7, K25, K39, and K72) have previously been shown to be involved in CCApaf-1 interaction ( Figure 5F ; Yu et al., 2001) , suggesting that nucleotide binding to these K residues will interfere with CC binding to Apaf-1. Structural modeling revealed that three other potential ATP binding sites on CC, i.e., K8, K27, and K73, were in the immediate vicinity of K7, K25, and K72, respectively ( Figure 5F ), suggesting that nucleotide binding to these K residues will likely also interfere with CC-Apaf-1 interactions. Indeed, prospective mutation of K8 into Ala (K8A) abolished the ability of CC to activate the Apaf-1-mediated caspase-9 activation ( Figure S4B ). In contrast, the wild-type CC induced robust caspase-9 activation that was inhibited, as expected, by increasing amounts of ATP ( Figure S4B , lanes 2-6). The other four K residues identified, i.e., K13, K86, K87, and K88 ( Figure 5F ), had not been studied with respect to their importance in CC-Apaf-1 interaction. Therefore, we carried out site-specific mutagenesis on wild-type human CC to create K13A, K86A, K87A, K88A, K86A/K87A, and K86A/K87A/K88A mutants. The results revealed that all these individual and compound mutant CC proteins failed to activate the Apaf-1-mediated caspase-9 activation ( Figure S4B ).
Intracellular Nucleotides as Critical Prosurvival Factors: Physiological Relevance
To determine whether nucleotides inhibit the CC-initiated apoptosis in vivo, we first microinjected CC into the cytoplasm of various cells to mimic CC release induced by apoptotic stimuli. Microinjection of CC (note that microinjected solutions generally get diluted $100-fold in the MALDI-MS spectra of CC (A); CC plus ATP at 10 mM (B), 100 mM (C), 500 mM (D), or 2 mM (E); CC plus 2 mM ADP (G) or 2 mM AMP (H). CC alone or CC with various nucleotides was coincubated, spotted on MALDI target, and spectra were acquired. The CC peak is at 12,231 and the other labeled peaks represent CC bound with different numbers of ATP molecules (B-E). In (G), one molecule of ADP ($428 Da) showed weak binding to CC (i.e., the peak at 12,659). (F) Modeling of potential ATP binding sites on CC using RasMol software (v2.6) based on PDB file 1HRC. The CC is depicted as helix-and-strand structure with ATP binding residues as space-filled balls. Of the 11 lysine residues (the aa numbers indicated) identified (Table S1) , four (i.e., K7, K25, K39, and K72) previously implicated in CC binding to Apaf-1 are indicated in red and the other seven in green. The yellow structure is the heme group. (I) IVT-C9 was incubated with Apaf-1 plus CC with or without various amounts of ATP (lanes 2-5). In lanes 6-8, CC was preincubated with 0-5 mM of ATP for 30 min at 37ºC and then unbound ATP was dialyzed out (overnight). Finally, the ATP bound CC was used in the reconstitution experiments. Chandra et al., 2002) . Some dead cells lost the coinjected Texas red dye ( Figure S5Cd , arrows). Cell death induced by the microinjected CC was Apaf-1 dependent as apoptosis was diminished in Apaf-1-deficient SKOV-3 cells or Apaf-1 À/À MEFs ( Figure S5D ). We then coinjected CC (3 mg/ml stock; final intracellular concentration $30 mg/ml) and various nucleotides into cells. Coinjection of dATP (1 mM stock; $[10 mM]) or ATP (100 mM stock; $[1 mM]) in PC3 ( Figure 6A ) or GM701 ( Figure S5E ) cells strongly inhibited the CC-induced cell death. Other NTPs or dNTPs coinjected into the PC3 cells also inhibited the CC-induced apoptosis ( Figure 6B ). Coinjection of dNTP ($[10 mM]) or NTP ($[1 mM]) pools into PC3, GM701, HeLa, MDA-MB231, and HMEC ( Figure 6C ) cells also inhibited the CC-induced cell death. If physiological levels of nucleotide pools exert such a dominant inhibitory effect on the CC-initiated apoptosome formation and caspase activation, how then do the stimulated cells die? One possibility is that persistent apoptotic stimulation might result in increasing CC release from the mitochondria, which would help to overcome the inhibitory effects of nucleotides. This possibility is partially supported by our demonstration that increasing amounts of microinjected CC induces more cell death ( Figures S5A  and S5B ). To further test this possibility, we carried out cell-free reconstitution experiments by incubating fresh GM701 cell cytosol with an increasing amount of CC in the presence of 0, 2, 3, or 5 mM ATP. We found that in the absence of exogenous ATP, addition of increasing amounts of CC led to correspondingly increased caspase-9 and -3 processing ( Figure 6D, lanes 2-8) . In the presence of 2-5 mM of ATP, caspase processing initiated by lower levels of CC (2-10 mg/ml) was inhibited, as evidenced by the levels of procaspase-9 bands and decreased levels of the processed caspase-9 and -3 fragments ( Figure 6D ; data not shown). However, higher concentrations of CC could partially overcome the inhibitory effects of ATP at 2-5 mM, as evidenced by increased apoptosome-derived p35 ( Figure 6D ; data not shown). Similarly, microinjection of higher amounts of CC to the (E) PC3 cells were microinjected with CC (either 3 mg/ml or 40 mg/ml stock) plus dATP (1 mM stock), ATP (10 mM stock), or dNTP (1 mM) or NTP (40 mM) pools. Apoptosis (%) in (A), (B), (C), and (E) was determined as described in Experimental Procedures. (F and G) GM701 (F) or MDA-MB231 (MDA; G) cells were treated with STS (0.5 mM) for the time intervals indicated. At the end, cells were harvested for Western for caspase-3 and DEVDase assays (insets) as well as NTP measurements by HPLC. All data represent the mean ± SD of two independent experiments. cells diminished the protective potential of coinjected nucleotides ( Figure 6E ).
Another possibility is that during apoptosis, the levels of (d)NTP pools, in particular, the ATP levels, might decline to allow CC to bind to Apaf-1. To directly test this possibility, we first measured the levels of ATP (and other NTPs) in several apoptotic systems. We observed that in GM701 cells treated with staurosporine (STS, staurosporine, a widely used kinase inhibitor that triggers intrinsic death pathway), caspase activation was directly correlated with prominent reductions in the levels of ATP ( Figures  6F and S6A ). In fact, there was a time-dependent decrease in the intracellular ATP levels and a corresponding increase in caspase activation ( Figures 6F and S6A) . Importantly, not only ATP levels but also other NTPs showed a time-dependent decrease ( Figures 6F and S6A ). Similar correlations between the decline in ATP (and NTP) levels and caspase activation were observed in the following: MDA-MB231 ( Figures 6G and S6B) or LNCaP ( Figure S6C ) cells treated with STS, MDA-MB231 cells treated with etoposide (VP16; Figure S6D ), multiple cell types treated with the BMD compound ( Figure S6E ), a mitochondrial toxin that upregulates the mitochondrial activities and triggers CC release (Chandra et al., 2002) , and HCT116 colon cancer cells treated with STS, Fas, and etoposide ( Figure S6F ). Decrease in ATP/NTP level early during apoptosis induction was not a consequence of caspase activation as z-VAD-FMK, a pan-caspase inhibitor, did not show any inhibitory effect (Table S3 ).
We then further tested the hypothesis that as the apoptotic process goes on, the levels of nucleotides bound to CC will also decrease in vivo to allow CC binding to Apaf-1. As shown in Figures S7A and S7B , STS induced a time-dependent release of CC into the cytosol of GM701 cells, and the nucleotide measurement of immunoprecipitated CC from the cytosols clearly demonstrated significantly reduced levels of bound ATP and NTP during apoptosis. A representative chromatogram is shown in Figure S7C . Similar decreases in ATP/NTP levels bound to CC were also observed in LNCaP cells stimulated with doxorubicin (data not shown).
If apoptotic stimulation induces a reduction in the intracellular NTP pools as well as in nucleotides bound to CC, which in turn contributes to the apoptotic process, exogenously introduced nucleotides should then inhibit the apoptotic stimuli-induced cell death. We observed that after 16 hr of BMD or STS treatment of PC3 cells, $60% surrounding uninjected cells underwent apoptosis whereas only $20% of the cells preinjected with (d)ATP showed apoptotic morphology (Figures 7A and 7B ; data not shown). (d)ATP similarly inhibited the BMD-induced GM701 cell death (Figures 7A and 7B ; data not shown). Many control (i.e., uninjected) PC3 cells treated with STS for 16 hr showed condensed or fragmented nuclei (Figure 7Bc, arrows) whereas most ATP-injected cells (Figure 7Bb, red) showed background-level DAPI staining and normal nuclei. Similarly, many GM701 cells treated with BMD for 4 hr became DAPI positive, whereas the majority of the ATP-injected cells were DAPI negative (Figures 7Be-7Bh) . Importantly, microinjection of nucleotides did not inhibit the apoptotic stimuli-induced CC release ( Figure S8 ), supporting that nucleotides exert their apoptosis-inhibitory effects downstream of CC release.
Finally, we carried out the reciprocal loss-of-function experiments. We used 2-deoxyglucose (DG) or DG plus sodium azide to first reduce the intracellular ATP and other NTPs ( Figure 7C and Table S4 ) and then microinjected cells with low amounts of CC (i.e., 0.001 mg/ml stock; $[0.01 mg/ml]), which by themselves did not induce appreciable cell death within 2 hr ( Figures 7D and S9) . Pretreatment with DG or DG plus azide reduced not only ATP but also, significantly, UTP (uridine triphosphate) and CTP (cytidine triphosphate) levels ( Figure 7C ). The DG plus azide treatment for 2 hr led to a reduction in total NTP concentrations by $50% (Table S4) or $60% ( Figure 7C ). Strikingly, even 30% reduction in cellular NTP levels by DG treatment alone ( Figure 7C ) rendered the cells much more susceptible to apoptosis induction by the low levels of microinjected CC ( Figures 7D and S9) . Interestingly, the DG plus azide treatment, which demonstrated a more potent ''depleting'' effect than DG alone ( Figure 7C ), also sensitized more cell death than DG ( Figure 7D ). Importantly, the CC-initiated cell death sensitized by NTP ''depletion'' was inhibited by either coinjection of ATP or refreshing cells in regular culture medium ( Figures 7D  and S9 ) with medium replenishment providing a more dramatic protective effect than ATP ( Figure 7D ), likely because the replenishment restored not only ATP but also other NTP levels ( Figure 7C) .
Some of the ATP might be hydrolyzed to ADP, which also demonstrates some inhibitory effect on the CC-initiated Apaf-1 activation ( Figure 1H ). Therefore, accompanying decreased ATP levels might be significant increases in ADP levels, which conceptually might neutralize the effect of the decreased ATP and other nucleotides. To exclude this possibility, we simultaneously measured ATP as well as other NTP concentrations together with ADP levels in the same set of samples, using the above-mentioned DG plus azide as a positive control. As shown in Table S4 , DG plus azide treatment decreased both ATP and ADP levels by $40%. Treatment of GM701 or MDA-MB231 cells with STS for 1 or 8 hr, respectively, when minimal caspase activation occurred (see Figures 6F and FG) , reduced the levels of ATP and other NTPs (Table S4 ). There was a slight increase in the ADP levels (Table S4) . However, compared with the decreases of NTP pools the marginal increases in ADP were negligible. Indeed, the combined concentrations of NTPs plus ADP in STS-treated GM701 or MDA-MB231 cells decreased by $60% and 45%, respectively (Table S4) , which should be sufficient to sensitize cells to apoptosis induction (see Figures 7C and 7D) .
Discussion
During the stress-induced cell death pathway, CC release from the mitochondria represents the key initiating event that eventually leads to caspase activation and demise of the cell. Nevertheless, it has also become clear that there exist postmitochondrial ''barriers'' in the cytoplasm that can inhibit the CC-initiated apoptotic process, the best known of which include intracellular ions (K + and Na + ) that directly inhibit apoptosome formation (Cain et al., 2001) and IAPs that inhibit the activities of the apoptosome-activated caspases (Shi, 2004 ). Here we show intracellular nucleotide pools as yet another class of molecules that can directly block the CC-initiated apoptosome formation and caspase activation. Reconstitution experiments using recombinant proteins have established a requirement for dATP (1-10 mM) or ATP (10-100 mM) in the CC/Apaf-1-mediated caspase activation in vitro (Jiang and Wang, 2000; Riedl et al., 2005) , which is confirmed in our own studies. Most cell-free experiments also utilize (d)ATP together with CC to initiate caspase activation. However, we find that, using cytosols freshly prepared from approximately ten different cell types, CC initiates robust caspase activation without requiring exogenous (d)ATP. The diluted cytosol used in our cell-free experiments contains $100 mM ATP (D.C. et al., unpublished data), which should be sufficient for the CC-induced caspase activation. One reason for the requirement of exogenous (d)ATP in others' cell-free experiments could be due to the use of stored samples, in which nucleotides may have been degraded.
The concentrations of dNTPs and NTPs in mammalian cells are $20-500 mM and $3-10 mM, respectively (Craig and Wallace, 1991; Miller and Horowitz, 1986; Mesner et al., 1999; Oliver et al., 1997; this study) . The concentrations of some NDPs and nucleotide intermediates are also in the mM range (e.g., ADP and NAD levels can be up to $0.5 and 1 mM, respectively [Paschen et al., 2000; Seto et al., 1985;  this study]). Therefore, our results suggest that nucleotides, nucleotide intermediates, and other related metabolic intermediates, combined, would pose a formidable ''brake'' on the CC-initiated apoptosome formation and subsequent caspase activation. In support, microinjected nucleotides inhibit apoptosis induced by CC as well as intrinsic death stimuli and extend cell survival. More importantly, experimentally reducing the ATP/NTP levels greatly sensitizes cells to the CC-initiated apoptosis. These ''gain-of-function'' and ''loss-of-function'' experiments thus concretely establish that intracellular nucleotides function as critical cellular survival factors in vivo. The proposal that endogenous nucleotides function as critical prosurvival factors is also supported by numerous experimental observations. In yeast, increased dNTP levels dramatically promote cell survival in response to DNA damage (Chabes et al., 2003) . Cellular nucleotide pools are required not only for T-lymphocyte proliferation but also for their survival (Quemeneur et al., 2003) . Nucleotide intermediate such as NADPH has recently been linked to oocyte survival (Nutt et al., 2005) . Similarly, increasing dNTP levels by overexpression of thymidine kinase (involved in de novo synthesis of dNTPs) or ribonucleotide reductase (RNR) (Grusch et al., 2001; Oliver et al., 1997) , as well as by supplementing cells with nucleotide precursors, confers resistance to apoptosis (Kelly et al., 2001) . Also, cancer cell death induced by commonly used chemotherapeutic drugs such as methotrexate and cis-platinum are mediated by drug-induced decreases of dNTP pools .
How do physiological levels of nucleotides inhibit the CC-initiated apoptosome formation? Our results provide convincing evidence that high concentrations of nucleotides directly interfere with CC binding to Apaf-1, the most upstream event in the CC-initiated apoptosome formation. The inhibitory effects of nucleotides and nucleotide intermediates seem to be related to the negative charges they carry. Hence, (d)NTPs, (d)NDPs, and (d)NMPs have four, three, and two negative charges, respectively, and they demonstrate an inhibitory effect in the order of (d)NTPs > (d)NDPs > (d)NMPs. NADP carries an extra negative charge compared to NAD and correspondingly shows a stronger inhibitory effect. Nucleotide analogs are also charged and are effective in inhibiting CC-induced caspase activation, whereas their uncharged nucleoside counterparts are without effect. These observations suggest that nucleotides may directly bind CC through electrostatic interactions. Indeed, the abilities of the nucleotides to bind to CC correlate well with the negative charges they carry (ATP > ADP > AMP).
Significantly, the ability of nucleotides to bind to CC also correlates well with their inhibitory effect on the CCinitiated caspase activation, suggesting that nucleotide binding to CC may mask sites on CC that are essential for its interaction with Apaf-1. CC interaction with Apaf-1 has been shown to be electrostatic and is mediated by the binding of multiple lysine residues on CC, including K7, K25, K39, and K72 to negatively charged aspartate residues in the Apaf-1 WD-40 domain (Purring-Koch and McLendon 2000; Yu et al., 2001) . The critical role of the CC K72 residue in CC-Apaf-1 interaction and caspase activation is highlighted by recent in vivo studies (Hao et al., 2005) . Our current study also implicates five other K residues (i.e., K8, K13, K86, K87, and K88) in mediating CC binding to Apaf-1 as the CC proteins with these sites mutated fail to activate Apaf-1-mediated caspase-9 activation.
How could cells override the barrier imposed by the intracellular nucleotides and their derivatives so that apoptosis can proceed? At least two mechanisms may cooperate to overcome the nucleotide barrier. First, persistent apoptotic stimulation may result in increased CC release resulting in increased caspase activation and cell death, as supported by our reconstitution and microinjection experiments using increasing amounts of CC. Our observations (D.C. and D.T., unpublished data), along with others' (Waterhouse et al., 2001) , suggest that cells contain 5-150 mM CC that can be released from the mitochondria during apoptotic stimulation, which might be sufficient to overwhelm the inhibitory effect of the nucleotides. Second, the ''brake'' deactivates by itself, i.e., apoptotic stimulation results in a decrease in intracellular nucleotide pools. Cell death induced by many other stimuli, such as cytokine withdrawal, chemicals, chemotherapeutic drugs, and ischemic injury, is also accompanied by a decrease in multiple nucleotides (Dagher, 2000; Grusch et al., 2001; Kelly et al., 2001; Oliver et al., 1997; Wang et al., 2005) . Moreover, during apoptotic stimulation, nucleotides may undergo distributional changes (Miller and Horowitz, 1986) or leak out of cells due to partially compromised membrane integrity. All of these could conceivably contribute to an overall decrease in the intracellular nucleotide pools.
Our model predicts that when small amounts of CC accidentally ''leak'' out of the mitochondria in normal cells or when small amounts of CC are released from the organelle early during apoptotic stimulation, the CC released into the cytosol shall be bound (or modified) by ATP as well as other nucleotide species, thus preventing it from interacting with Apaf-1. However, in the persistent presence of apoptotic stimulation and mitochondrial damage, increased CC release, together with decreases (or alterations) of nucleotides and their intermediates, would result in the removal of the ''nucleotide brake'' and activation of the Apaf-1 apoptosome. The concerted actions of these two mechanisms suggest that when CC release reaches a certain threshold and nucleotides decrease to a certain level, the existing nucleotides will no longer be sufficient to block CC interaction with Apaf-1, thus allowing Apaf-1 oligomerization and apoptosome assembly to occur. This model potentially reconciles the apparent paradox in which high levels of nucleotides inhibit while lower levels of (d)ATP activate the apoptosome. It should be pointed out, however, that the demonstrated requirements for low levels of (d)ATP in the CC-initiated apoptosome formation are, to our knowledge, all based on in vitro cellfree or recombinant protein reconstitution experiments, and the precise roles of (d)ATP in apoptosome activation in the cells remain yet to be determined. Since the NTP levels are significantly higher than those of dNTPs, our results suggest that NTPs (particularly ATP) probably play a more prominent role in regulating both cell survival and death. The key role of CC in ATP synthesis ensures a balance between its metabolic (antiapoptotic) and proapoptotic roles. This may provide a mechanism that protects cells from inappropriate CC release from mitochondria. Regardless, our observations, together with recent studies showing that ATP at R1 mM also negatively regulates caspase-9 through direct binding (Chereau et al., 2005) and that apoptosome formation appears to require dATP hydrolysis and nucleotide exchange on Apaf-1 (Kim et al., 2005) , suggest that the functions of nucleotides in regulating apoptosome formation and caspase activation in vivo are more complicated than we previously considered. Finally, our results provide both mechanistic insights on the cell-killing effects of many anticancer drugs and an exploratory foundation to help design novel, and in particular, nucleotide-based, antineoplastic agents.
EXPERIMENTAL PROCEDURES
Cell-Free Reconstitution
All cell-free reactions were performed in homogenizing buffer in a total volume of 100 ml (Chandra and Tang, 2003) . Briefly, cytosols were activated by adding bovine CC (15 mg/ml) with or without (d)ATP and incubated for 150 min at 37ºC. In some experiments, cytosols were activated in the presence of various nucleotides and salts. In others, either XIAP-immunodepleted cytosol or recombinant purified Smac was added in the reaction mixture. After incubation samples were either used for substrate cleavage assays for caspase-9 (LEHDase) and caspase-3 (DEVDase) or caspase cleavage by Western blotting. Alternatively, purified Apaf-1XL was incubated with IVT, 35 S-labeled procaspase-9 (TNT T7 Quick; Promega) with CC (1 mM) in the presence of nucleotides for 60 min at 30ºC in oligomerization buffer. After incubation, the sample buffer was added and proteins resolved by SDS-PAGE followed by autoradiography.
Analysis of Apoptosome Complexes
Control, CC-activated, or CC/dATP-activated cytosols were fractionated by size-exclusion chromatography using Superose 6 HR 10/30 column (Amersham Pharmacia Biotech). Apoptosome complexes ($700 kDa) were eluted using column buffer (20 mM HEPES, 0.1% (w/v) CHAPS, 5 mM DTT, 5% (w/v) sucrose pH 7.0) supplemented with 50 mM NaCl. Different fractions were then analyzed by Western blotting for changes in the distribution of Apaf-1 and processing of caspase-3 and -9 (Cain et al., 2000) .
Microinjection
Cell microinjection was performed in 6 cm tissue culture dish using an Eppendorf pressure injector (model 5246) and micromanipulator model (model 5171). Microinjection needles (inner diameter, $0.1 mm) were purchased from Eppendorf and loaded using Eppendorf microloaders. Dextran-Texas red (MW 10,000 lysine fixable, Molecular Probes; 0.2% final concentration) with different combinations of CC and nucleotides was injected into the cytoplasm of various cells (pressure, time, 0.3 s) . Immediately after injection, cells were replenished with fresh medium. An average of 100-150 cells were microinjected for each condition and injected cells were scored for apoptosis based on morphology and DAPI staining (Chandra et al., 2002) . Details for cells; reagents, basic apoptosis protocols, Far Western blotting, immunoprecipitation, site-specific mutagenesis of CC, expression and purifications of proteins, CC modifications by MALDI-MS and sites of CC modifications, and the determination of NTP and dNTP levels are provided in Supplemental Experimental Procedures.
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